Latest News > Portfolio Company News

GREAT POINT PARTNERS PORTFOLIO COMPANY JPA HEALTH COMPLETES ACQUISITION OF BIOCENTRIC, INC.

GREENWICH, Conn – May 23, 2024 – Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, today announced that its portfolio company, JPA Health, completed the acquisition of BioCentric, Inc. (“Biocentric”), an award-winning medical communications agency recognized for its work supporting leading pharmaceutical companies with scientific platforms for pipeline product candidates, clinical trial acceleration, and HCP engagement.

JPA Health, a global full-service, integrated agency that serves biopharmaceutical, medical device, non-profit, and public health clients, operates from Washington D.C., Boston, New York, and London. JPA Health’s strategic offerings include providing end-to-end integrated medical affairs, clinical development, commercial strategy, creative marketing, public relations, and patient advocacy solutions to clients.

“We are thrilled to welcome BioCentric into the growing JPA Health family,” said Carrie Jones, CEO of JPA Health. “This acquisition is a great union, bringing together BioCentric’s medical prowess with JPA’s deeply rooted expertise across marketing, patient advocacy, and corporate communications. Our clients will benefit from a fully integrated agency that can deliver unparalleled solutions to help them achieve their goals efficiently and effectively.”

“After a comprehensive search to find the right medical communications agency, we could not be more excited about the union of JPA Health and BioCentric’s talented professionals,” said Bret Tenenhaus, Principal at Great Point Partners. “We look forward to supporting JPA Health’s continued growth through client expansion, partnerships, and acquisitions.”

BioCentric will serve as JPA Health’s medical communications and learning experiences arm, leveraging its innovative gamification approach to enhance engagements, capture meaningful insights, and drive positive behavior change. Sherine Aly, who founded BioCentric in 2001, joins JPA Health as Executive Vice President of Medical Communications.

“Joining JPA Health provides us with new cutting-edge capabilities to better serve our clients,” said Sherine Aly, Executive Vice President, Medical Communications.  “Our shared commitment to improving lives by connecting healthcare stakeholders and leveraging the latest technological innovations will unlock powerful and creative synergies.  Together, we can now offer our clients end-to-end solutions that make a real difference in patients’ lives.”

This acquisition follows JPA Health’s purchase of True North Solutions in September 2023, further expanding the agency’s capabilities in predictive analytics, AI, and natural language processing. With the integration of True North Solutions and BioCentric, JPA Health continues to build on its mission to provide comprehensive, data-driven, and high-impact services to clients across the life sciences, public health, one health, and federal government sectors.

About Great Point Partners

Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new minority and majority private equity investments from GPP IV. Great Point manages approximately $1.7B of capital (including committed and uncalled capital) in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device contract manufacturing and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.

JPA Health
JPA Health is an award-winning independent, full-service agency established in 2007. With offices across the U.S. and Europe, the agency seamlessly brings together flexible solutions in public relations, commercial marketing, patient advocacy, and medical communications across the health sector. Leveraging tailored AI solutions, JPA Health crafts seamless, 360-degree omnichannel strategies to engage healthcare stakeholders effectively. As a women-owned and independent agency, we are passionate about helping people live healthier lives and dedicated to pushing the boundaries of healthcare communications.

For more information about JPA Health and its comprehensive suite of services, please visit www.jpa.com.

BioCentric – A JPA Health Company

BioCentric is an award-winning medical communications and learning experiences agency that supports a broad range of drug development and commercialization activities. With expertise in behavioral science, modern learning principles, and game mechanics, BioCentric creates value-based, customer-centric experiences to improve patient care.